Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Low-dose LSD looks safe for Alzheimer’s patients, but will it work?
Earlier studies point to potential benefits for LSD in depression, anxiety, and substance abuse, and Eleusis’ hope is that low dose LSD may also have significant potential in treating Alzheimer’s,
Latest news
-
Karuna’s shares spike on schizophrenia drug data
anxiety, that can seriously limit the clinical effectiveness of current antipsychotic drugs, most of which have been in use for decades.
-
Prescription drug dependence 'linked to deprivation', says PHE
This included benzodiazepines for anxiety and insomnia, z-drugs for insomnia, gapapentinoids for neuropathic pain, opioid pain medications for chronic non-cancer pain and antidepressants.
-
Pear Therapeutics submits latest digital therapeutic, insomnia and depression treatment
Pear Therapeutics says the study also showed improvements in anxiety symptoms (as measured by the General Anxiety Disorder 7-item (GAD-7) scale), with a treatment arm mean of 3.16
-
Otsuka’s Alzheimer’s agitation drug hits the mark
antipsychotic drugs – which have been linked to a higher risk of death in dementia – as well as antidepressants and anxiety medications.
-
Hidden health system costs: false positives and negatives
And maybe I suffer from some stress and anxiety. Or a false negative?
More from news
Approximately 1 fully matching, plus 148 partially matching documents found.
Latest Intelligence
-
Growing up as a patient is hard to manage
Not only do many patients experience anxiety as a result of an unfamiliar care team, undefined degree of control or unexpected changes to therapy, but they can also face system-level
-
Integrating patient reported outcomes into clinical trials
However, the HTA acknowledges the limitations of the index, noting that “the DLQI has limited validity in some people, and may miss anxiety and depression.”.
-
Changing healthcare communications
Replacing anxiety with confidence, mediocrity with purpose. By David Hunt and Lou Shipley. ... But only if we replace anxiety with confidence, mediocrity with purpose, and attract the brightest, smartest and most creative minds to join our cause.
-
Drug launches to watch in 2019
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
AstraZeneca’s oncology renaissance
Galbraith is concerned about the rise in reported anxiety and mental health problems in young people, with young women most vulnerable.
More from intelligence
Approximately 0 fully matching, plus 19 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
War on drugs: the use of controlled substances in medicine
Psilocybin (aka magic mushrooms) has shown promise in treating a variety of difficult-to-treat health conditions such as depression and cancer-related anxiety.
-
Remote Working: Join the Revolution Workshop
UK band Marconi Union incorporated scientific theory with the expertise of sound therapists to create‘Weightless’, a piece of music specifically composed to reduce anxiety, blood pressure and heart rate; try ... The second webinar will focus more on
-
HARNESSING TECHNOLOGY TO TRANSFORM HEALTHCARE IN THE DIGITAL AGE
This technology has applications for fears and phobias, in depression, anxiety, PTSD and even schizophrenia.
-
From nature to art galleries: thinking differently about healthcare
Doctors in Shetland can now prescribe nature to their patients in a programme which seeks to reduce blood pressure and anxiety amongst other things.
-
The era of digital wellbeing
However, it’s rise in popularity has resulted in both positive and negative outcomes, with the latter increasing bullying, depression and anxiety the world over. ... depression, anxiety, aggression, and antisocial behaviour.
More from PMHub
Approximately 1 fully matching, plus 30 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Biogen delays filing of Alzheimer’s drug, which hits its share price
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Alnylam and Vir plan gene-silencing attack on COVID-19 virus
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
infill healthcare communication
infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
